During the study period, 1930 patients were transferred and admitted to our hospital via rotary- or fixed-wing aircraft. We excluded 50 patients who met the exclusion criteria. Finally, 1880 patients were analyzed in the study (Figure 1).
Patient characteristics and crude outcomes (APACHE-II score and in-hospital mortality) are shown in Table 1. There were no significant differences observed in age, sex diagnostic categories and flight time between the non-CT and CT groups. Median age was 72 years (IQR, 59–82 years) and flight time was 70 min (IQR, 53–93 min). The CT group had significantly higher APACHE-II scores compared with the non-CT group [12 (IQR, 8–17) vs. 10.5 (IQR, 7–14), p=0.007]. In-hospital mortality did not significantly differ between the two groups [CT group, 8.4% vs. non-CT group, 4.4%, p=0.10].
Table 1
Baseline characteristics and outcomes before adjustment
Variables | Non-CT group (n=136) | CT group (n=1,744) | P-value |
Age, years, median (IQR) | 68.5 (51.5–83.5) | 72 (59–82) | 0.25 |
Sex, male (%) | 90 (66.2) | 1,105 (63.4) | 0.51 |
Diagnosis (%) | | | |
Cerebrovascular disease | 21 (15.4) | 359 (20.6) | 0.051 |
Infectious disease and sepsis | 20 (14.7) | 261 (15.0) | |
Gastrointestinal disease | 25 (18.4) | 260 (14.9) | |
Cardiovascular disease | 18 (13.2) | 380 (21.8) | |
Trauma | 24 (17.6) | 243 (13.9) | |
Respiratory disease | 16 (11.8) | 128 (7.3) | |
Others | 12 (5.9) | 113 (6.5) | |
Flight time, min, median (IQR) | 73 (54–93.5) | 69 (53–93) | 0.99 |
Outcomes | | | |
APACHE–II score, median (IQR) | 10.5 (7–14) | 12 (8–17) | 0.007 |
In-hospital mortality (%) | 6 (4.4) | 146 (8.4) | 0.10 |
CT, computed tomography; IQR, Interquartile range; APACHE, acute physiology and chronic health evaluation |
Wilcoxon rank sum test for continuous variables and chi-square test for categorical variables were used for the comparison.
The results of multivariable linear regression analysis for disease severity assessed by APACHE-II score are shown in Table 2. Availability of CT was significantly associated with higher APACHE-II scores excluding the age points [coefficient, 1.30; 95% confidence interval, 0.13–2.47; p=0.029]. Older age and longer flight times were also significantly associated with greater severity of disease.
Table 2
Multivariable linear regression analysis for severity of disease assessed by APACHE-II score (n=1,880)
Variable | Coefficient | (95% CI) | P-value |
Availability of CT | 1.30 | (0.13 to 2.47) | 0.029 |
Age (per year) | 0.05 | (0.03 to 0.07) | <0.001 |
Sex, male | 0.14 | (-0.54 to 0.81) | 0.69 |
Flight time (per min) | -0.01 | (-0.02 to -0.01) | <0.001 |
Diagnosis | | | |
Cerebrovascular disease | Reference | | |
Infectious disease and sepsis | -0.52 | (-1.64 to 0.6) | 0.36 |
Gastrointestinal disease | -1.40 | (-2.39 to -0.42) | 0.005 |
Cardiovascular disease | -0.10 | (-1.11 to 0.92) | 0.86 |
Trauma | -1.21 | (-2.25 to -0.17) | 0.022 |
Respiratory disease | 0.91 | (-0.43 to 2.25) | 0.18 |
Others | 2.99 | (1.28 to 4.69) | 0.001 |
APACHE, acute physiology and chronic health evaluation; CI, confidence interval; CT, computed tomography |
Table 3 shows the results of the multivariable logistic regression analysis for in-hospital mortality. Availability of CTs was not significantly associated with in-hospital mortality [odds ratio, 1.66; 95% confidence interval, 0.66–4.21; p=0.28]. Older age and higher APACHE-II scores—excluding the age points—were significantly associated with higher mortality.
Table 3
Multivariable logistic regression analysis for in-hospital mortality (n=1,880)
Variables | Odds ratio | (95% CI) | P-value |
Availability of CT | 1.66 | (0.66 to 4.21) | 0.28 |
Age (per year) | 1.03 | (1.01 to 1.04) | <0.001 |
Sex, male | 0.99 | (0.67 to 1.48) | 0.97 |
Flight time (per min) | 1.00 | (0.99 to 1.00) | 0.051 |
Diagnosis | | | |
Cerebrovascular disease | Reference | | |
Infectious disease and sepsis | 0.77 | (0.40 to 1.46) | 0.42 |
Gastrointestinal disease | 0.79 | (0.41 to 1.52) | 0.48 |
Cardiovascular disease | 0.83 | (0.48 to 1.45) | 0.51 |
Trauma | 0.94 | (0.50 to 1.77) | 0.85 |
Respiratory disease | 2.09 | (1.08 to 4.06) | 0.029 |
Others | 0.58 | (0.25 to 1.34) | 0.20 |
APACHE-II score† | 1.14 | (1.12 to 1.17) | <0.001 |
CI, confidence interval; CT, computed tomography; APACHE, acute physiology and chronic health evaluation |
†APACHE-II scores were calculated excluding age points. |